机构名称：
¥ 9.0
), our preclinical model data, our pipeline targets, our other programs and business operations, our current and planned partnerships and collaborators and the intended benefits thereof, including the collaboration with Lilly and the intended benefits thereof, including the upfront payment, equity investment, and milestone and royalty payments from commercial product sales, if any, from the products covered by the collaboration, as well as the potential of our technologies and product candidates;我们最新的战略计划及其预期利益，我们的计划为我们的眼科资产寻求战略合作伙伴关系以及我们的财务状况和现金跑道。前瞻性陈述基于管理层的信念和假设以及仅在本演讲之日起提供给管理的信息。我们的实际结果可能与这些预期的结果有重大不同
2024年12月11日
主要关键词
相关文件推荐
